This site became the new ClinicalTrials.gov on June 19th. Learn more.
Show more
ClinicalTrials.gov Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more...
ClinicalTrials.gov Menu
Give us feedback

A Study of Motexafin Gadolinium for the Treatment of Relapsed or Refractory Multiple Myeloma

This study has been completed.
Sponsor:
Information provided by:
Pharmacyclics LLC.
ClinicalTrials.gov Identifier:
NCT00096837
First received: November 16, 2004
Last updated: June 7, 2006
Last verified: June 2006
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: No date given
  Primary Completion Date: No date given